13F Pro quality score
Rank #1,155 of 2,925TOP 50%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Ardent Health, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $6.3B | $135.8M | 4.5% |
| FY 2024 | 10-K | $6.0B | $210.3M | 6.1% |
| FY 2023 | 10-K | $5.4B | $53.9M | 2.8% |
| FY 2022 | 10-K | $5.1B | $188.9M | 6.1% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Ardent Health, Inc. (ARDT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ARDT at 56.5/100 on a composite quality score built from its SEC filings, placing it at rank #1,155 of 2,925 stocks — the top half of the AI-ranked universe. ARDT scores in the top quartile across earnings quality (97.6), revenue scale (81.2). Areas of concern include profitability (30.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Ardent Health, Inc. reports quarterly revenue of $1.6B, net income of $16.9M, an operating margin of 2.7%. Top institutional holders of ARDT by reported 13-F value include CHAI, Ventas, BlackRock, based on the most recent SEC filings. ARDT trades on the NYSE exchange and files with the SEC under CIK 1756655. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARDT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ardent Health, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1756655 →